Fig. 3From: Heterogeneous response and progression patterns reveal phenotypic heterogeneity of tyrosine kinase inhibitor response in metastatic renal cell carcinomaVenn diagram of response patterns. Percentage of 27 patients with the indicated combination of lesion response categories based on a the assessment of the best response achieved per lesion and b assessment on the specific scan showing the best overall response. RL Responding Lesion, SL Stable Lesion, PL Progressing LesionBack to article page